Current status of resistance to antibiotics in the Democratic Republic of the Congo: A review

J Glob Antimicrob Resist. 2020 Sep:22:818-825. doi: 10.1016/j.jgar.2020.07.008. Epub 2020 Jul 18.

Abstract

A review of literature was conducted to assess the prevalence and mechanisms of antibiotic resistance to date, mainly to β-lactam antibiotics, cephalosporins, carbapenems, colistin, and tigecycline in the Democratic Republic of the Congo (DRC). English and French publications were listed and analysed using PubMed/Medline, Google Scholar, and African Journals database between 1 January 1990 and 31 December 2019. For the 30 published articles found: (1) bacterial resistance to antibiotics concerned both Gram-negative and Gram-positive bacteria; (2) multidrug resistance prevalence was the same in half of Streptococcus pneumoniae isolates; (3) a worrying prevalence of methicillin-resistant Staphylococcus aureus (MRSA) was noted, which is associated with co-resistance to several other antibiotics; and (4) resistance to third-generation cephalosporins was very high in Enterobacteriaceae, mainly because of blaCTX-M-1 group and blaSHV genes. Data on carbapenem and colistin resistance were not available in DRC until recently. Further work is required to set up a surveillance system for antibiotic resistance in DRC.

Keywords: Antimicrobial resistance genes; Democratic Republic of the Congo; Enterobacteriaceae; Extended-spectrum β-lactamases; Methicillin-resistant Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Democratic Republic of the Congo / epidemiology
  • Enterobacteriaceae
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents